Gut microflora in the pathogenesis of the complications of cirrhosis

Best Practice and Research: Clinical Gastroenterology

Volumn 18, Issue 2, 2004, Pages 353-372

  Garcia Tsao, Guadalupe ^a   Wiest, Reiner ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Bacterial translocation; Cirrhosis; Gut flora; Hepatic encephalopathy; Hyperdynamic circulation; Intestinal bacterial overgrowth; Intestinal permeability; Spontaneous bacterial peritonitis

Indexed keywords

AMMONIA; ANTIBIOTIC AGENT; ANTIOXIDANT; BILE ACID; CISAPRIDE; COTRIMOXAZOLE; GLYCOCHOLIC ACID; LACTITOL; LACTULOSE; METRONIDAZOLE; NEOMYCIN; NORFLOXACIN; PAROMOMYCIN; PLACEBO; PROBIOTIC AGENT; PROKINETIC AGENT; PROPRANOLOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAXIMIN; VEGETABLE PROTEIN;

ANTIBIOTIC RESISTANCE; ASCITES; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; DISEASE PREDISPOSITION; ESCHERICHIA COLI; ESOPHAGUS VARICES BLEEDING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEPATIC ENCEPHALOPATHY; HUMAN; IMMUNE DEFICIENCY; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSIT TIME; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PLANTARUM; LAPAROTOMY; LIVER CIRCULATION; LIVER CIRRHOSIS; PATHOGENESIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PROTEIN DIET; REVIEW; SPLANCHNIC BLOOD FLOW; VASCULAR RESISTANCE; VASODILATATION;

ASCITES; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; ENTEROBACTERIACEAE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; PERITONITIS; SPLANCHNIC CIRCULATION; VASODILATION;

EID: 1842453220     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2003.10.005     Document Type: Review

References (124)

1. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: varices and variceal hemorrhage, ascites and spontaneous bacterial peritonitis Gastroenterology 120 2001 726-748
2. Groszmann R.J. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences Hepatology 20 1994 1359-1363
3. Yoshida H. Hamada T. Inuzuka S. et al. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma American Journal of Gastroenterology 88 1993 2067-2071
4. Deschenes M. Villeneuve J.P. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis American Journal of Gastroenterology 94 1999 2193-2197
5. Caly W.R. Strauss E. A prospective study of bacterial infections in patients with cirrhosis Journal of Hepatology 18 1993 353-358
6. Fernandez J. Navasa M. Gomez J. et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis Hepatology 35 2002 140-148
7. Borzio M. Salerno F. Piantoni L. et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study Digestive and Liver Disease 33 2001 41-48
8. Thulstrup A.M. Sorensen H.T. Schonheyder H.C. et al. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis Clinical Infectious Diseases 31 2000 1357-1361
9. Bleichner G. Boulanger R. Squara P. et al. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal hemorrhage British Journal of Surgery 73 1986 724-726
10. Follo A. Llovet J.M. Navasa M. et al. Renal impairment following spontaneous bacterial peritonitis in cirrhosis. Incidence, clinical course, predictive factors and prognosis Hepatology 20 1994 1495-1501
11. Toledo C. Salmeron J.M. Rimola A. et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime Hepatology 17 1993 251-257
12. Navasa M. Follo A. Llovet J.M. et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis Gastroenterology 111 1996 1011-1017
13. Sort P. Navasa M. Arroyo V. et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis New England Journal of Medicine 341 1999 403-409
14. Terg R. Cobas S. Fassio E. et al. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study Journal of Hepatology 33 2000 564-569
15. Bernard B. Cadranel J.F. Valla D. et al. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study Gastroenterology 108 1995 1828-1834
16. Goulis J. Armonis A. Patch D. et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage Hepatology 27 1998 1207-1212
17. Vivas S. Rodriguez M. Palacio M.A. et al. Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding Digestive Diseased Sciences 46 2001 2752-2757
18. Campillo B. Richardet J.P. Kheo T. Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection Clinical Infectious Diseases 35 2002 1-10
19. Llovet J.M. Rodriguez-Iglesias P. Moitinho E. et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes Journal of Hepatology 26 1997 88-95
20. Campillo B. Dupeyron C. Richardet J.P. et al. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin Clinical Infectious Diseases 26 1998 1066-1070
21. Wiest R. Rath H.C. Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut Best Practice and Research Clinical Gastroenterology 17 2003 397-425
22. Garcia-Tsao G. Spontaneous bacterial peritonitis Gastroenterology Clinics of North America 21 1992 257-275
23. Garcia-Tsao G. Albillos A. Barden G.E. West A.B. Bacterial translocation in acute and chronic portal hypertension Hepatology 17 1993 1081-1085
24. Garcia-Tsao G. Lee F.Y. Barden G.E. et al. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites Gastroenterology 108 1995 1835-1841
25. Garcia-Tsao G. Bacterial translocation: cause or consequence of decompensation in cirrhosis? Journal of Hepatology 34 2001 150-155
26. Kasravi F.B. Wang L. Wang X.D. et al. Bacterial translocation in acute liver injury induced by d-galactosamine Hepatology 23 1996 97-103
27. Wells C.L. Erlandsen S.L. Localization of translocating Escherichia coli, Proteus mirabilis, and Enterococcus faecalis within cecal and colonic tissues of monoassociated mice Infection and Immunity 59 1991 4693-4697
28. Deitch E.A. Taylor M. Grisham M. et al. Endotoxin induces bacterial translocation and increases xanthine oxidase activity Journal of Trauma 29 1989 1679-1683
29. Chiva M. Guarner C. Peralta C. et al. Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats European Journal of Gastroenterology Hepatology 15 2003 145-150
30. Koh I.H. Guatelli R. Montero E.F. et al. Where is the site of bacterial translocation-small or large bowel? Transplantation Proceedings 28 1996 2661
31. Pardo A. Bartoli R. Lorenzo-Zuniga V. et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis Hepatology 31 2000 858-863
32. Ferri M. Gabriel S. Gavelli A. et al. Bacterial translocation during portal clamping for liver resection Archives of Surgery 132 1997 162-165
33. Cirera I. Bauer T.M. Navasa M. et al. Bacterial translocation of enteric organisms in patients with cirrhosis Journal of Hepatology 34 2001 32-37
34. Genesca J. Marti R. Rojo F. et al. Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites Gut 52 2003 1054-1059
35. Such J. Frances R. Munoz C. et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites Hepatology 36 2002 135-141
36. Fierer J. Finley F. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver Journal of Clinical Investigatim 63 1979 912-921
37. Hassner A. Kletter Y. Shlag D. et al. Impaired monocyte function in liver cirrhosis British Medical Journal 282 1981 1262-1263
38. Akalin H.E. Laleli Y. Telatar H. Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis Quarterly Journal of Medicine 56 1985 431-437
39. Garcia-Gonzalez M. Boixeda D. Herrero D. Burgaleta C. Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis Gastroenterology 105 1993 527-531
40. Mellencamp M.A. Preheim P.C. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae Journal of Infectious Disease 163 1991 102-108
41. Finlayson N.D. Krohn K. Fauconnet M.H. Anderson K.E. Significance of serum complement levels in chronic liver disease Gastroenterology 63 1972 653-659
42. Homann C. Varming K. Hogasen K. et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality Gut 40 1997 544-549
43. Rimola A. Soto R. Bory F. et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis Hepatology 4 1984 53-58
44. Zweifach B.W. Benacerraf B. Effect of hemorrhagic shock on the phagocytic function of Kupffer cells Circulation Research 6 1958 83-87
45. Altura B.M. Hershey S.G. Sequential changes in reticuloendothelial system function after acute hemorrhage Proceedings of the Society of Experimental Biology and Medicine 139 1972 935-939
46. Llovet J.M. Bartoli R. Planas R. et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock Hepatology 23 1996 781-787
47. Perez-Paramo M. Munoz J. Albillos A. et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites Hepatology 31 2000 43-48
48. Morencos F.C. De las Heras G. Ramos M. et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis Digestive Diseases Sciences 40 1995 1252-1256
49. Yang C.Y. Chang C.S. Chen G.H. Small intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests Scandinavian Journal of Gastroenterology 33 1998 867-871
50. Chang C.S. Chen G.H. Lien H.C. Yeh H.Z. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis Hepatology 28 1998 1187-1190
51. Bauer T.M. Steinbruckner B. Brinkmann F.E. et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis American Journal of Gastroenterology 96 2001 2962-2967
52. Chesta J. Defilippi C. Abnormalities in proximal small bowel motility in patients with cirrhosis Hepatology 17 1993 828-832
53. Madrid A.M. Cumsille F. Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease Digestive Diseases and Sciences 42 1997 738-742
54. Veal N. Auduberteau H. Lemarie C. et al. Effects of octreotide on intestinal transit and bacterial translocation in conscious rats with portal hypertension and liver fibrosis Digestive Diseases and Sciences 46 2001 2367-2373
55. Astaldi G. Strosselli E. Peroral biopsy of the intestinal mucosa in hepatic cirrhosis American Journal of Digestive Diseases 5 1960 603-612
56. Ramchandran A. Prabhu R. Thomas S. et al. Intestinal mucosal alterations in experimental cirrhosis in the rat: role of oxygen free radicals Hepatology 35 2002 622-629
57. Ljungdahl M. Lundholm M. Katouli M. et al. Bacterial translocation in experimental shock is dependent on the strains in the intestinal flora Scandinavian Journal of Gastroenterology 35 2000 389-397
58. Zhang S.C. Wang W. Ren W.Y. et al. Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis World Journal of Gastroenterology 9 2003 534-538
59. Budillon G. Parilli G. Pacella M. et al. Investigation of intestine and liver function in cirrhosis using combined sugar oral loads Journal of Hepatology 1 1985 513-524
60. Campillo B. Pernet P. Bories P.N. et al. Intestinal permeability in liver cirrhosis: relationship with severe septic complications European Journal of Gastroenterology and Hepatology 11 1999 755-759
61. Llovet J.M. Bartoli R. March F. et al. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence Journal of Hepatology 28 1998 307-313
62. Rimola A. Bory F. Teres J. et al Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage Hepatology 5 1985 463-467
63. Soriano G. Guarner C. Tomas A. et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage Gastroenterology 103 1992 1267-1272
64. Gines P. Rimola A. Planas R. et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial Hepatology 12 1990 716-724
65. Grange J.D. Roulot D. Pelletier G. et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites - a double-blind randomized trial Journal of Hepatology 29 1998 430-436
66. Panes J. Perez-del-Pulgar S. Casadevall M. et al. Impaired mesenteric leukocyte recruitment in experimental portal hypertension in the rat Hepatology 30 1999 445-453
67. Llach J. Gines P. Arroyo V. et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites Gastroenterology 94 1988 482-487
68. Wiest R. Groszmann R.J. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough Hepatology 35 2002 478-491
69. Pizcueta P. Pique J.M. Fernandez M. et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition Gastroenterology 103 1992 1909-1915
70. Niederberger M. Martin P.Y. Gines P. et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats Gastroenterology 109 1995 1624-1630
71. Vallance P. Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 337 1991 776-778
72. Lin R.S. Lee F.Y. Lee S.D. et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation Journal of Hepatology 22 1995 165-172
73. Bigatello L.M. Broitman S.A. Fattori L. et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients American Journal of Gastroenterology 82 1987 11-15
74. Guarner C. Soriano G. Tomas A. et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia Hepatology 18 1993 1139-1143
75. Chu C.J. Lee F.Y. Wang S.S. et al. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide Clinical Sciences 93 1997 219-225
76. Albillos A. de la Hera A. Gonzalez M. et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement Hepatology 37 2003 208-217
77. Lopez-Talavera J.C. Cadelina G. Olchowski J. et al. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats Hepatology 23 1996 1616-1621
78. Battista S. Bar F. Mengozzi G. et al. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins Journal of Hepatology 26 1997 75-80
79. Wiest R. Tsai M.-H. Garcia-Tsao G. et al. Bacterial translocation up-regulates GTP-cyclohydrolase I in mesenteric vasculature of cirrhotic rats Hepatology 2003 (in press)
80. Lumsden A.B. Henderson J.M. Kutner M.H. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis Hepatology 8 1988 232-236
81. Mainous M.R. Ertel W. Chaudry I.H. Deitch E.A. The gut: a cytokine-generating organ in systemic inflammation? Shock 4 1995 193-199
82. Deitch E.A. Xu D. Franko L. et al. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock Shock 1 1994 141-145
83. Guo W. Ding J. Huang Q. Deitch E.A. Alterations in intestinal bacterial flora modulate the systemic cytokine response to hemorrhagic shock American Journal of Physiology 269 1995 G827-G832
84. Wiest R. Das S. Cadelina G. et al. Bacterial translocation to lymph nodes of cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility Journal of Clinical Investigation 104 1999 1223-1233
85. Panes J. Perry M. Anderson D. et al. Portal hypertension enhances endotoxin-induced intercellular adhesion molecule 1 up-regulation in the rat Gastroenterology 110 1996 866-874
86. McClain C.J. Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis Hepatology 9 1989 349-351
87. Deitch E.A. Ma L. Ma W.J. et al. Inhibition of endotoxin-induced bacterial translocation in mice Journal of Clinical Investigation 84 1989 36-42
88. Unno N. Wang H. Menconi M.J. et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats Gastroenterology 113 1997 1246-1257
89. Nadler E.P. Ford H.R. Regulation of bacterial translocation by nitric oxide Pediatric Surgery International 16 2000 165-168
90. Chin-Dusting J.P. Rasaratnam B. Jennings J.L. Dudley F.J. Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis Annals of Internal Medicine 127 1997 985-988
91. Rabiller A. Nunes H. Lebrec D. et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome American Journal of Respiratory and Critical Care Medicine 166 2002 514-517
92. Guarner C. Runyon B.A. Heck M. et al. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats Digestive Diseases and Sciences 44 1999 1957-1962
93. Runyon B.A. Borzio M. Young S. et al. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis Hepatology 21 1995 1719-1724
94. Bauer T.M. Fernandez J. Navasa M. et al. Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis Journal of Hepatology 36 2002 501-506
95. Bernard B. Grange J.D. Khac E.N. et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis Hepatology 29 1999 1655-1661
96. Novella M. Sola R. Soriano G. et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin Hepatology 25 1997 532-536
97. Madrid A.M. Hurtado C. Venegas M. et al. Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function American Journal of Gastroenterology 96 2001 1251-1255
98. Wiest R. Chen F. Cadelina G. et al. Effect of Lactobacillus-fermented diets on bacterial translocation and intestinal flora in experimental prehepatic portal hypertension Digestive Diseases and Sciences 48 2003 1136-1141
99. Rayes N. Seehofer D. Hansen S. et al. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients Transplantation 74 2002 123-127
100. Chiva M. Soriano G. Rochat I. et al. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis Journal of Hepatology 37 2002 456-462
101. Slocum M.M. Sittig K.M. Specian R.D. Deitch E.A. Absence of intestinal bile promotes bacterial translocation The American Surgeon 58 1992 305-310
102. Burke V. Stone D.E. Beaman J. Gracey M. Effects of biliary diversion on intestinal microflora in the rat Journal of Medical Microbiology 10 1977 241-244
103. Lorenzo-Zuniga V. Bartoli R. Planas R. et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats Hepatology 37 2003 551-557
104. Strauss E. da Costa M.F. The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis Hepatogastroenterology 45 1998 900-904
105. Schalm S.W. Van Der May T. Hyperammonemic coma after hepatectomy in germ-free rats Gastroenterology 77 1979 231-234
106. Hawkins R.A. Jessy J. Mans A.M. et al. Neomycin reduces the intestinal production of ammonia from glutamine Advances in Experimental Biology Medicine 368 2003 125-134
107. Avallone R. Zeneroli M.L. Venturini I. et al. Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy Gut 42 1998 861-867
108. Mullen K.D. Szauter K.M. Kaminsky-Russ K. Endogenous benzodiazepine activity in body fluids of patients with hepatic encephalopathy Lancet 336 1990 81-83
109. Yurdaydin C. Walsh T.J. Engler H.D. et al. Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy Brain Research 679 1995 42-48
110. Schafer D.F. Fowler J.M. Jones E.A. Colonic bacteria: a source of gamma-aminobutyric acid in blood Proceedings of the Society of Experimental Biology and Medicine 167 1981 301-303
111. al Mardini H. al Jumaili B. Record C.O. Burke D. Effect of protein and lactulose on the production of gamma-aminobutyric acid by faecal Escherichia coli Gut 32 1991 1007-1010
112. Zullo A. Hassan C. Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal Journal of Clinical Gastroenterology 37 2003 164-168
113. Huber M. Rossle M. Siegerstetter V. et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis Hepatogastroenterology 48 2001 541-544
114. Leger L. Lenriot J.P. Fourestier M. Goiffon B. The role of total colectomy in portacaval encephalopathy Journal de Chirurgie (Paris) 103 1972 437-450
115. McDermott W.V. Victor M. Point W.W. Exclusion of the colon in the treatment of hepatic encephalopathy New England Journal of Medicine 267 1962 850-854
116. Chapman M.L. Janowitz H.D. Chronic portal-systemic encephalopathy after ileostomy and colonic resection Lancet i 1966 1064-1065
117. Riggio O. Varriale M. Testore G.P. et al. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients Journal of Clinical Gastroenterology 12 1990 433-436
118. Uribe M. Marquez M.A. Garcia-Ramos G. et al. Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients Digestive Diseases and Sciences 25 1980 924-928
119. Ferenci P. Herneth A. Steindl P. Newer approaches to therapy of hepatic encephalopathy Seminars in Liver Diseases 16 1996 329-338
120. Zeneroli M.L. Venturini I. Stefanelli S. et al. Antibacterial activity of rifaximin reduces the levels of benzodiazepine-like compounds in patients with liver cirrhosis Pharmacology and Therapeutics 35 1997 557-560
121. Macbeth W.A. Kass E.H. McDermott W.V. Treatment of hepatic encephalopathy by alterations of intestinal flora with Lactobacillus acidophilus Lancet 191 1965 399-403
122. Read A.E. McCarthy C.F. Heaton K.W. Laidlaw J. Lactobacillus acidophilus (enpac) in treatment of hepatic encephalopathy British Medical Journal 5498 1966 1267-1269
123. Loguercio C. Abbiati R. Rinaldi M. et al. Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy Journal of Hepatology 23 1995 39-46
124. Weber F.L.Jr. Minco D. Fresard K.M. Banwell J.G. Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects Gastroenterology 89 1985 538-544